Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Anna Liza B. Durol"'
Autor:
von Moltke Ll, Johanna P. Daily, David J. Greenblatt, Richard I. Shader, Anna Liza B. Durol, Jennifer A. Graf, Jerold S. Harmatz, Hoffman Jl, Polyxane Mertzanis
Publikováno v:
Journal of Acquired Immune Deficiency Syndromes. 24:129-136
BACKGROUND The viral protease inhibitor ritonavir has the capacity to inhibit and induce the activity of cytochrome P450-3A (CYP3A) isoforms, leading to drug interactions that may influence the efficacy and toxicity of other antiretroviral therapies,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4024e24981f7a638850c73640d7fc854
https://doi.org/10.1097/00042560-200006010-00007
https://doi.org/10.1097/00042560-200006010-00007
Autor:
Lisa L. von Moltke, Richard I. Shader, Su Xiang Duan, Jennifer A. Graf, Anna Liza B. Durol, Jerold S. Harmatz, Polyxane Mertzanis, Molly Counihan, David J. Greenblatt, C. Eugene Wright
Publikováno v:
Clinical Pharmacology & Therapeutics. 64:278-285
Background Macrolide antimicrobial agents may impair hepatic clearance of drugs metabolized by cytochrome P4503A isoforms. Potential interactions of triazolam, a substrate metabolized almost entirely by cytochrome P4503A in humans, with 3 commonly pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74d9821de5db43de8b1fbb3dc424fa1d
https://doi.org/10.1016/s0009-9236(98)90176-x
https://doi.org/10.1016/s0009-9236(98)90176-x
Publikováno v:
European Journal of Clinical Pharmacology. 56:259-261
Objective: Biotransformation of triazolam to its α-hydroxy and 4-hydroxy metabolites by human liver microsomes in vitro was used as an index of human cytochrome P 450 3A (CYP3A) activity. Results: The reaction was strongly inhibited by co-incubation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bd6d15c935a1e825af2b75fad370a93
https://doi.org/10.1007/s002280000125
https://doi.org/10.1007/s002280000125
Autor:
Anna Liza B. Durol, Johanna P. Daily, Lisa L. von Moltke, Jennifer A. Graf, Polyxane Mertzanis, Richard I. Shader, David J. Greenblatt, Jonathan L. Hoffman, Jerold S. Harmatz
Publikováno v:
Clinical pharmacology and therapeutics. 67(4)
Background Pharmacokinetic interactions involving antiretroviral therapies may critically influence the efficacy and toxicity of these drugs, as well as pharmacologic treatments of coincident or complicating diseases. The viral protease inhibitor rit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7b003a5b52cecc45d4365b11c64fa12
https://pubmed.ncbi.nlm.nih.gov/10801241
https://pubmed.ncbi.nlm.nih.gov/10801241
Publikováno v:
Journal of analytical toxicology. 21(5)
Zolpidem, an imidazopyradine hypnotic agent, can be quantitated by high-performance liquid chromatography (HPLC) with fluorescence detection. After the addition of a structurally related internal standard (propyl-zolpidem), plasma samples were double
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d09189c6cecf2b9bcc96c92d1c5c9b9
https://pubmed.ncbi.nlm.nih.gov/9288593
https://pubmed.ncbi.nlm.nih.gov/9288593